Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Adj TC + Herceptin Early Stage Breast Cancer

This study has been completed.
Sponsor:
Collaborator:
Sanofi
Information provided by (Responsible Party):
US Oncology Research
ClinicalTrials.gov Identifier:
NCT00493649
First received: June 27, 2007
Last updated: May 19, 2014
Last verified: May 2014